CollaMedix Inc. specializes in innovative medical devices utilizing proprietary electrocompaction technology to create advanced collagen-based biomaterials. This patented electrocompaction (ELAC) process transforms solubilized medical-grade collagen into high-density, aligned threads, resulting in a macroporous biofabric known as CollaFabric™. Unlike traditional collagen products, which often exhibit random orientation and loose packing, CollaMedix's electrocompacted collagen threads maintain a structure that closely mimics native collagen, enhancing their mechanical strength and bioinductive properties. This unique alignment not only improves the tensile strength of the collagen but also promotes a favorable biological response, guiding the deposition of new collagen in vivo, which is crucial for effective soft tissue repair and augmentation.

The company is actively developing two primary products: CollaSleeve® for orthopedic applications, specifically targeting rotator cuff repairs, and CollaSling® for treating stress urinary incontinence in women. CollaSleeve® functions as a tubular braided scaffold that enhances tissue healing by facilitating organized collagen deposition at the repair site, thereby reducing retear rates associated with traditional repair methods. Similarly, CollaSling® is designed as a bio-inspired sling that supports the urethra while promoting biocompatibility and effective tissue repair through its unique collagen structure. Both products leverage the advanced properties of CollaMedix's electrocompacted collagen to address significant clinical needs in their respective fields.

United States

CollaMedix develops medical devices that are based on collagen. These devices are made using electrocompaction technology. Electrocompacted collagen devices can enhance soft tissue repair and augmentation. One example is CollaFabric®, a load-bearing fabric made from collagen.

CollaMedix

Company Details